Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.
Seven Network’s former director of program partnerships is suing the national broadcaster for putting her on unpaid maternity leave and extending her non-compete period after she resigned for rival Network Ten.
The first class action is expected to be filed on behalf of property owners whose buildings are covered with highly combustible polyethylene core cladding.
A month after successfully arguing for the recusal of a state Supreme Court justice from an upcoming trial over the collapse of Queensland Nickel, Clive Palmer is calling for the replacement judge to step down, alleging he too is biased against him.
Geoffrey Rush’s co-star Eryn Jean Norvill took the stand Tuesday in the actor’s defamation case against Nationwide News, telling a court she felt “panicked” and “trapped” by Rush’s allegedly inappropriate behaviour during a production of King Lear at the Sydney Theatre Company.
Wyeth must pay a group of generic drug companies for the harm they suffered after the drug maker won interlocutory injunctions blocking their plans to market an extended release generic version of anti-depressant Effexor, in a ruling likely to have a chilling effect on interlocutory injunction grants in pharmaceutical patent cases.
The Australian Workers Union has called on the Federal Court to toss AstraZeneca’s challenge to a decision that workers are guaranteed 10 days’ sick leave regardless of how long their working day is.
Hong Kong-based conglomerate CITIC and two of its subsidiaries have taken mining magnate Clive Palmer and his firm Mineralogy to court over the $5.8 billion Sino Iron Ore Project in Western Australia.
The high-stakes contest to run a shareholder class action against BHP has begun, with lawyers for three competing cases all arguing in Federal Court Monday that there can be only one winner.
A four-day trial against online ticket reseller Viagogo kicked off Monday, with the ACCC describing how the site misled consumers by falsely claiming it was an official ticket vendor, hitting them with a booking fee of around 28 per cent along the way.